AIM
AMPH icon

Alambic Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Alambic Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-29,423
Closed -$583K – 286
2019
Q3 		$583K Sell
29,423
-32,200
-52% -$671K 0.44% 88
2019
Q2 		$1.3M Sell
61,623
-6,941
-10% -$145K 0.8% 25
2019
Q1 		$1.4M Buy
68,564
+53,800
+364% +$1.21M 0.57% 47
2018
Q4 		$294K Buy
+14,764
New +$291K 0.12% 219

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alambic Investment Management's AMPH Position: Q4 2019 in Review

Alambic Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2019, closing a stake of 29,423 shares — an estimated $583K sold.

Alambic Investment Management first reported a position in AMPH in Q4 2018 and held it in 4 quarters. The position peaked at $1.4M in Q1 2019. 119 funds tracked by Wall St. Rank hold AMPH as of Q4 2019.

  • Alambic Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Alambic Investment Management sold 29,423 Amphastar Pharmaceuticals shares in Q4 2019, an estimated $583K.
  • Alambic Investment Management first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Alambic Investment Management's Amphastar Pharmaceuticals position peaked at $1.4M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2019.

Based on Alambic Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.